mesna · Baxter Hlthcare · NDA 019884, 020855
Mesnex
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220518, Eugia Pharma · 019884-001Approved 27 Jan 2026Detected 25 Oct 2026Historical import
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 019884 · 001 · RLD | injectable, intravenous | 100MG/ML | open |
| 020855 · 001 · RLD | tablet, oral | 400MG | open |